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Background: Although highly homologous to MBD2, the functional role of MBD3 remains in question.
Results: MBD3 preferentially localizes to methylated and, to a lesser degree, unmethylated CpG dinucleotides.
Conclusion: Dynamic distribution between methylated and unmethylated sites modifies the genomic localization of MBD3.
Significance: Changes in the dynamic distribution on DNA dictate functional differences between MBD proteins.
Although highly homologous to other methylcytosine-bind-
ing domain (MBD) proteins, MBD3 does not selectively bind
methylated DNA, and thus the functional role of MBD3 remains
in question. To explore the structural basis of its binding prop-
erties and potential function, we characterized the solution
structure and binding distribution of the MBD3 MBD on
hydroxymethylated, methylated, and unmethylated DNA. The
overall fold of this domain is very similar to other MBDs, yet a
key loop involved in DNA binding is more disordered than pre-
viously observed. Specific recognition of methylated DNA con-
strains the structure of this loop and results in large chemical
shift changes in NMR spectra. Based on these spectral changes,
we show that MBD3 preferentially localizes to methylated and,
to a lesser degree, unmethylated cytosine-guanosine dinucle-
otides (CpGs), yet does not distinguish between hydroxymeth-
ylated and unmethylated sites. Measuring residual dipolar cou-
plings for the different bound states clearly shows that the
MBD3 structure does not change between methylation-specific
and nonspecific binding modes. Furthermore, residual dipolar
couplings measured for MBD3 bound to methylated DNA can
be described by a linear combination of those for the methyla-
tion and nonspecific binding modes, confirming the preferential
localization to methylated sites. The highly homologous MBD2
protein shows similar but much stronger localization to meth-
ylated as well as unmethylated CpGs. Together, these data
establish the structural basis for the relative distribution of
MBD2 and MBD3 on genomic DNA and their observed occu-
pancy at active and inactive CpG-rich promoters.
The mammalian methylcytosine-binding domain proteins
(MeCP2 and MBD1– 4) selectively bind symmetrically meth-
ylated CpGs through a common methylcytosine-binding
domain (MBD)2 (1) and likely arose from a gene duplication
event of a single common ancestral protein (MBD2/3) (2). The
preference of MBD2 for methylated DNA has been retained in
both invertebrates and vertebrates; (3); however, the highly
homologous MBD3 shows little to no preference for meth-
ylated DNA as a result of key differences in amino acids critical
for DNA contact within the MBD (4, 5). Both proteins recruit a
nucleosome remodeling and deacetylase (NuRD) complex (6)
but in a mutually exclusive manner (7). The MBD2-NuRD com-
plex has been specifically shown to promote methylation-de-
pendent gene silencing and represents a potential therapeutic
target for gene reactivation (6, 8 –13), whereas the function of
the MBD3-NuRD complex has not been clearly delineated.
A recent study showed that MBD3 co-localizes with Tet1 and
suggested preferential binding to hydroxymethylated CpGs
(hmCpG) (14). Subsequent experiments, however, failed to
show a binding affinity preference for hmCpG (15) but instead
found that both MBD2 and MBD3 preferentially localize to
transcriptional start sites with CGIs (16, 17). MBD2 predomi-
nates at methylated CGIs, and the associated genes show
reduced expression, whereas MBD3 appears to favor transcrip-
tional start sites with unmethylated CGIs and is enriched at
active promoters (16).
To help elucidate the structural differences between MBD2
and MBD3 and evaluate the recently proposed hydroxymeth-
ylation selectivity (14), we determined the structure of MBD3
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bound to DNA containing a single hmCpG dinucleotide. We
observed that MBD3 adopts a structure very similar to that of
MBD2. A critical loop connecting two anti-parallel  strands is
less well defined in MBD3, but otherwise the two structures are
nearly identical. Furthermore, we show that MBD3 does not
specifically recognize hmCpG, but chemical shift analysis indi-
cates that MBD3 binds differently to mCpG and spends a sig-
nificant proportion of time on methylated sites. Occupancy
depends on the number of unmethylated sites available, and
MBD3 demonstrates chemical shift averaging indicative of fast
exchange between the methylated and nonspecific binding
modes. Residual dipolar coupling (RDC) analysis confirms our
findings by showing that MBD3 preferentially localizes to
mCpG sites and that MBD3 adopts a very similar structure on
mCpG, CpG, and hmCpG DNA. As expected, MBD2 shows a
strong preference for mCpG sites, exclusively localizing to the
mCpG dinucleotide. We also find that MBD2 localization is
influenced by unmethylated CpG density and that MBD2
shows an unanticipated additional weak localization to
hmCpG.
Taken together, this information leads to a model in which
the methylation specificity and occupancy of an MBD can be
titrated by single amino acid substitutions. Importantly, the
tendency to localize on a specific site does not necessarily trans-
late into a global binding affinity preference. These data are
consistent with recent studies showing that both MBD2 and
MBD3 localize to transcription start sites associated with CGIs
(16, 17). The ability to condense chromatin and silence tran-
scription at or near methylated CGIs reflects MBD2 high affin-
ity and stable occupancy of mCpG sites. Hence, we propose that
MBD3 evolved, at least in part, to counterbalance MBD2 on
unmethylated CGIs. The presence of MBD3 at unmethylated
CGIs could modify the distribution of MBD2 and potentially
mitigate strong silencing by the high affinity, more strongly
localizing MBD2 protein, thereby preserving bivalency with
respect to transcription.
EXPERIMENTAL PROCEDURES
Purification of Proteins and DNA—The methylcytosine-
binding domain of MBD3 (amino acid residues 1–70) was cloned,
expressed, and purified as described previously for cMBD2 (18).
17- and 27-bp complementary oligonucleotides (Table 1) were
purchased (Integrated DNA Technologies), annealed, and puri-
fied as described previously (18). The sequences were derived
from the p16INK4a promoter known to be a native target
sequence for MBD2 (5).
NMR Spectroscopy—Purified protein was combined with
10% excess purified dsDNA and buffer exchanged into 10 mM
NaPO4, pH 6.5, 1 mM dithiothreitol, 10% 2H2O, and 0.02%
sodium azide and concentrated to 0.2–1 mM. NMR spectra
from standard experiments for resonance assignments, dis-
tance, and torsional angle restraints were collected on a Bruker
Avance III 700-MHz instrument. The data were processed
using NMRPipe (19) and analyzed with CcpNmr (20). Residual
dipolar couplings were measured for complexes containing
2H,13C,15N-labeled protein using standard in-phase/anti-phase
experiments and samples aligned by adding 12 mg/ml pf1
bacteriophage (Asla Biotech, Ltd.). For each aligned sample, a
one-dimensional 2H spectrum of 2H2O was collected, and the
deuterium quadrupole splitting was measured. When compar-
ing RDC values between samples, the observed RDC values
were normalized to an effective deuterium quadrupole splitting
of 10 Hz.
Structure Calculations—The structure of the MBD3 MBD
was calculated by simulated annealing as implemented in the
Xplor-NIH software package (21) and based on NOE-derived
distance constraints, torsion angle restraints, and residual dipo-
lar couplings, as well as a torsion angle database potential of
mean force (22) and a quartic van der Waals repulsion term for
nonbonded contacts (23). Backbone torsional angle restraints
were derived from chemical shifts using the TALOS software
(24), and hydrogen bond distance and angle restraints were
introduced based on backbone torsional angles and character-
istic NOE patterns.
Binding Affinity—Binding affinities were determined by sur-
face plasmon resonance analysis on a Biacore T100 system (GE
Healthcare) as described previously (18). The binding affinity
was determined from steady state analysis of the SPR relative
response at varying concentrations of protein. As previously
shown, the maximum steady state response (Rmax) in SPR
depends on stoichiometry (n) of binding (25). Prior to fitting,
the steady state response at each protein concentration (RA)
was normalized (Rnorm) to the total DNA immobilized (Rl) and






Final data analysis, plotting, and curve fitting were performed
with pro Fit software (QuantumSoft).
RESULTS
Solution Structure of the MBD3 MBD Is Nearly Identical to
That of MBD2—We determined the solution structure of the
MBD from MBD3 (amino acids 1–70) bound to a 17-bp dsDNA
with a central hydroxymethylated CpG dinucleotide. The
structure was calculated based on 528 NOE-derived distance
constraints, 120 dihedral angle restraints, and 53 residual dipo-
lar coupling restraints (Table 2). The overall protein structure is
well defined (Fig. 1, A and B) with average pairwise root mean
square deviations (RMSD) of 0.7  0.1 Å (backbone) and 1.2 
0.1 Å (all heavy atoms) for ordered regions (residues 6 –23 and
TABLE 1
DNA sequences
The lengths and nucleotide sequences are given for the different dsDNA molecules
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34 –71). As expected, the fold is very similar to that of chicken
MBD2 (cMBD2; RMSD  2.0  0.1 Å) for the same ordered
regions (Fig. 1D) (18).
As with all MBD proteins studied to date, the topology of the
MBD comprises a four-stranded -sheet followed by a single
-helix and a C-terminal loop. The central two strands of the
-sheet (2 and 3) form a long finger-like projection that can
extend down and across the major groove of DNA to make base
specific contacts. The most notable difference between the
cMBD2 and MBD3 structures is that the loop connecting the
long fingerlike projection is not as well ordered in MBD3 (res-
idues 24 –33; Fig. 1, A and C) with an RMSD of 1.7  0.5 Å
(backbone) as compared with cMBD2 with an RMSD of 0.9 
0.3 Å. Residues at the base of this loop form critical DNA spe-
cific contacts and a hydrogen bond network that stabilizes the
interaction with the methylated CpG dinucleotide (Fig. 1E).
Predicting backbone order parameters (S2) based on chemi-
cal shifts using the random coil index method (24, 26) confirms
that this loop is less well ordered in MBD3 (Fig. 2). The differ-
ence in predicted S2 between complexes shows that residues
24 –33 become progressively more ordered between the
MBD3-hmCpG, MBD3-mCpG, and cMBD2-mCpG com-
plexes, respectively. Thus in the absence of a methylation-spe-
cific binding mode, the loop connecting the central two
-strands is more flexible.
Filtered intermolecular NOE spectra did not contain NOE
cross-peaks, which is consistent with the observed line broad-
ening for residues at the DNA interface and the overall lower
affinity of MBD3 for DNA and suggests nonspecific protein-
DNA interaction with dynamic exchange between binding
sites. Based on subsequent analyses that indicate MBD3 prefer-
entially localizes to methylated sites, we collected filtered NOE
spectra for MBD3 bound to methylated DNA (mCpG). Like-
FIGURE 1. Solution structure of MBD3 methyl-binding domain bound to hydroxymethylated DNA. A, stereo ribbon diagram (blue) of the MBD3 solution
structure is shown for the ensemble of 20 calculated structures (Protein Data Bank code 2mb7). The loop connecting 2 and 3 (residues 24 –33) is highlighted
in light blue. B, ribbon diagram of the lowest energy solution structure is shown with key contact and chemical shift reporter residues depicted as sticks. C, per
residue RMSD for backbone atoms is plotted for the solution structure ensemble of MBD3 (blue) and for the solution structure ensemble of cMBD2 (red)
previously reported (Protein Data Bank code 2ky8) (18). D, the best fit protein alignment of the solution structures of cMBD2 (green) and MBD3 (blue) MBD is
shown bound to the methylated DNA from the cMBD2-dsDNA solution structure (Protein Data Bank code 2ky8). E, diagram highlighting the cMBD2 hydrogen-
bonding network while bound to methylated DNA and with key residues depicted as sticks. Structure diagrams were generated using the PyMOL program
(Delano Scientific LLC).
TABLE 2
NMR and refinement statistics
The number and type of structural constraints as well as the final refinement statis-
tics are presented for the solution structure of MBD3 bound to hydroxymethylated
DNA.
Protein





Sequential (i  j  1) 155
Medium range (i  j  4) 111
Long range (i  j  5) 160
Hydrogen bonds 32









Violations (mean and S.D.)
Distance constraints (Å) 0.018  0.003
Dihedral angle constraints (°) 0.4  0.1
Maximum dihedral angle violation (°) 4.8
Maximum distance constraint violation (Å) 0.48
Deviations from idealized geometry (mean and S.D.)
Bond lengths (Å) 0.04  0.01
Bond angles (°) 0.69  0.002
Impropers (°) 2.01  0.006
Average pairwise RMSD (Å)a
Heavy 1.2  0.1
Backbone 0.7  0.1
Ramachandran plot summary for ordered residues
Most favored regions 92.4%
Additionally allowed regions 7.4%
Generously allowed regions 0.2%
Disallowed regions 0.0%
a Pairwise RMSD and S.D. from the mean was calculated among 20 (of 50)
lowest energy refined structures for ordered residues (residues 6 –23 and
34 –71).
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wise, we did not detect any intermolecular NOE cross-peaks
with methylated DNA, indicating that MBD3 exchanges among
different binding modes whether on methylated or hydroxy-
methylated DNA. Given the absence of informative intermo-
lecular NOEs, we did not determine a solution structure of the
protein-DNA complex. Importantly, we noted that chemical
shifts of MBD3 bound to hmCpG (discussed in detail below) are
more similar to MBD3 on unmethylated DNA than methylated
DNA, which led us to compare spectra of MBD3 on different
DNA molecules to probe both methylation-specific and non-
specific DNA association.
MBD3 Spends a Significant Portion of Time on Methylated
Sites—As first described for MeCP2 (27) and later described for
cMBD2 (18), a pair of highly conserved arginine residues in
MBD proteins form bidentate hydrogen bonds with the sym-
metrically opposed guanine bases of an mCpG dinucleotide
(Fig. 1E). The aliphatic portion of each arginine packs against
the methyl group of the neighboring methylcytosine. Given
that an unmethylated CpG contains symmetrically opposed
guanines, we hypothesized that MBDs should still recognize the
CpG dinucleotide, but with lower affinity. Even though MBD3
binds DNA with lower overall affinity and shows less selectivity
for methylated DNA, the critical arginine residues are con-
served and could provide sequence specific recognition of CpG
dinucleotides.
In 15N HSQC spectra, we noted that several cross-peaks that
showed unusual chemical shifts for cMBD2-mCpG did not
show the same chemical shifts for MBD3-hmCpG (Fig. 3B). In
particular, the 1H	 of Arg24, which forms a side chain hydrogen
bond with Asp32 and is shifted far downfield (9.5 ppm) in
cMBD2-mCpG, is only shifted to 7.5 ppm in MBD3. Likewise,
Gly27 is shifted upfield in 15N to 102 ppm in cMBD2-mCpG, but
not to the same degree in MBD3-hmCpG (105 ppm), and finally
Ala30 is shifted upfield in 1H to 6.8 ppm in cMBD2-mCpG but
only 7.6 ppm in MBD3-hmCpG.
We hypothesized that these large chemical shift changes
reflect a difference between methylation-specific and nonspe-
cific binding modes. Arg24 and Asp32 are positioned at the N
and C termini of the poorly structured loop in MBD3, whereas
Ala30 and Gly27 also fall within this same loop. Methylation-
specific binding stabilizes the Arg24–Asp32 H-bond and the
loop containing Gly27 and Ala30. To test this hypothesis, we
compared HSQCs for MBD3 bound to a DNA sequence with
three CpG dinucleotides in which the central CpG is meth-
ylated (mCpG), hydroxymethylated (hmCpG), or unmethy-
lated (CpG(3)), as well as similar DNA sequences with only
one (CpG(1)) or no CpGs (CpG(0)) (Table 1). We found
that the chemical shifts of these reporter resonances fall on a
line between extrema represented by cMBD2-mCpG and
MBD3-CpG(0). Importantly, the peak position for each of the
reporter resonances falls at the same fractional distance
between these extrema (Fig. 3B), shifting toward the position in
the cMBD2-mCpG complex as the number of unmethylated
CpG sites increases and with the addition of a methylated CpG.
These observations strongly indicate chemical shift averaging
between two binding modes (28) reflective of fast exchange
between methylation-specific and nonsequence specific interac-
tion with DNA. Furthermore, the chemical shift changes are con-
sistent with preferential localization at the CpG and mCpG sites.
Using cMBD2 as representative of the methylation-specific
binding mode could introduce structural and primary sequence
differences that affect observed chemical shifts. Therefore we
sought to generate an MBD3 MBD that binds with high selec-
tivity for mCpG, which would allow us to evaluate chemical
shift changes for more backbone resonances with fewer con-
founding sequence variations. Previous studies have estab-
lished that the lack of mCpG specificity for MBD3 reflects two
amino acids (His30 and Phe34) that differ from other MBD pro-
teins (Lys32 and Tyr36 in cMBD2) (4, 5). We introduced the
H30K,F34Y double mutation into MBD3 (MBD3KY), and as
expected, this mutant bound with higher affinity and selectivity for
mCpG comparable to cMBD2 (Fig. 7 and Table 3). Each of the
reporter resonances now show chemical shifts that are very similar
to those of the cMBD2-mCpG complex, confirming that the
unique chemical shifts do reflect a methylation-specific binding
mode.
To further explore the chemical shift changes associated with
the different binding modes, we assigned the backbone reso-
nances (15N,1H) for MBD3 bound to mCpG or CpG(3) and
MBD3KY bound to mCpG. In Fig. 3A, the chemical shift dis-
tances are plotted for backbone resonances between the differ-
ent complexes. The largest chemical shift changes are seen for
the poorly structured loop (residues 24 –33) when comparing
the MBD3KY-mCpG and MBD3-mCpG complexes with the
MBD3-hmCpG complex. In contrast, the 15N HSQC spectra
FIGURE 2. Methyl-specific binding mode stabilizes a dynamic loop in
MBD3. A, ribbon diagram of the MBD3 solution structure is shown and col-
ored based on order parameters predicted from chemical shift index (S2;
shading from blue to red reflects low to high). B, the predicted order parame-
ters (S2) are plotted for the MBD3-hmCpG (black), MBD3-mCpG (blue dotted),
and cMBD2-mCpG (red) complexes. C, bar plots are shown for the difference
in order parameters (	S2) between the cMBD2-mCpG complex and MBD3-
mCpG (black) and MBD3-hmCpG (gray) complexes. The loop connecting 2
and 3 (residues 24 –33) is highlighted in light yellow in B and C.
The Dynamic Distribution of MBD3 on DNA
JANUARY 17, 2014 • VOLUME 289 • NUMBER 3 JOURNAL OF BIOLOGICAL CHEMISTRY 1297
for the MBD3-hmCpG and MBD3-CpG(3) complexes show
nearly identical chemical shifts and spectra (Fig. 4A).
These observations strongly support a binding model in
which MBD3 exhibits fast exchange between methylation-spe-
cific and nonspecific binding. Thus the observed chemical shift
(
obs) reflects a weighted average of the methylation-specific
(
MBD3(KY)-mCpG) and nonspecific (
MBD3-CpG(3)) binding
modes, as given by Equation 2,

obs  m  
MBD3KY-mCpG  
1  m  
MBD3-CpG
x3 (Eq. 2)
where m is the fraction in the methylation-specific binding
mode. Hence, these chemical shifts are direct measures of the
average time spent on the mCpG site. Using 11 backbone
1H,15N resonances that show a clear linear relationship
between chemical shift and DNA bound, we find that MBD3
spends 43% (5%) of the time on the mCpG site (Fig. 3B).
These data further indicate that, despite a lack of a strong
global binding affinity preference for mCpG DNA, MBD3 still
spends a significant proportion of time on methylated sites. To
confirm that this finding was not the result of very weak binding
with chemical shift averaging between DNA bound and free
MBD3, we compared HSQCs for 600 and 300 M samples of
protein on DNA. The peaks for each reporter residue show
nearly identical chemical shifts at both concentrations (Fig. 5B),
indicating that the observed chemical shift changes of the
reporter residues were not the result of exchange between
bound and free states but instead represent averaging between
different bound states. The observed differences in chemical
shift represent changes in the binding distribution on DNA, not
changes in the distribution between bound and free states.
We developed a statistical-mechanical model to describe the
distribution of MBD3 on methylated DNA (Fig. 3C) in which
the partition function comprises a sum of Boltzmann factors
(eE(i)/kT) for methylation-specific and nonspecific binding
modes, 	E is the difference in energy between binding modes,
and N is the number of nonspecific sites. The additional meth-
ylation-specific interactions formed by MBD2 lead to a larger
FIGURE 3. Preferential localization of MBD3 to mCpG sites. A, bar plots show the chemical shift distances between MBD3-dsDNA complexes. B, an overlay of 15N
HSQC spectra are shown for key reporter residues of MBD3 bound to CpG(0), CpG(1), CpG(3), mCpG, and hmCpG as well as MBD3KY and cMBD2 bound to mCpG.
C, the derivation of a simple statistical mechanical model for the distribution of MBD3 on mCpG (top panel) is shown with a mixed rendering diagram (bottom panel)
depicting MBD3 docked onto a methylated site (red) as well as four nonmethylated sites (blue) of the mCpG DNA. Arrows indicate rapid exchange between these
binding modes. D, overlays of 15N HSQC spectra are shown for key reporter residues of MBD3 and MBD3KY while bound to DNA of varying lengths.
TABLE 3
Binding affinity
The dissociation constant (KD), Rmax, and 2 values are given for different protein
and DNA complexes as determined by steady state analysis of surface plasmon
resonance studies.
Protein DNA KD  S.E. Rmaxa 2 (103)
M





MBD3KY mCpG) 0.13  0.01 1.0 2.6
MBD3KY CpG(3) 17  2 2.1 1.8
MBD2 mCpG 0.11  0.01 0.8 1.0
MBD2 CpG(3) 74  4 4.8 3.8
MBD2 CpG(1) 78  7 4.8 7.2
MBD2 CpG(0) 68  3 5.4 5.9
MBD2 hmCpG 54  8 4.3 51
a Normalized such that Rmax reflects stoichiometry.
b Weak binding and solubility limits preclude accurate determination of binding
affinity.
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	E, thereby increasing m and the relative selectivity for mCpG.
Without these interactions, MBD3 shows a smaller 	E, m is
reduced but still not 0, and MBD3 distributes unevenly between
mCpGs and unmethylated sites. Fig. 3C depicts a simplified
structural model of this distribution in which the MBD3 struc-
ture was docked onto the 17-bp DNA fragment at the centrally
methylated mCpG (red) as well as four “nonspecific” binding
sites (blue). The statistical model further indicates that localiz-
ing to an mCpG depends on the number of nonspecific sites
available (N) and therefore the length of DNA. We tested this
latter prediction by comparing chemical shifts for the reporter
residues of MBD3 on 10-, 17-, and 27-bp DNA with a single
mCpG (Fig. 3D). Indeed, we found that increasing DNA length
results in chemical shift changes for Gly27 and Ala30 toward the
unmethylated binding mode.
Residual Dipolar Couplings Confirm MBD3 Localizes to
Methylated Sites without Significant Conformational Change—
As an alternative method to assess the ensemble of binding
modes, we measured residual dipolar couplings (1DNH) for
MBD3 bound to methylated and unmethylated DNA as well as
for MBD3KY bound to methylated DNA. As can be seen in Fig.
5, the observed 1DNH are similar but not identical between the
different complexes. When plotting 1DNH from the unmethyl-
ated complex against those from wild type MBD3 or MBD3KY
methylated complexes, the data fall off of the line of identity
(y  x), as highlighted by the red dotted ovals in Fig. 5 (A and B).
Because the observed residual dipolar couplings reflect a
weighted average of the different binding modes (29), the 1DNH
for each residue (n) of MBD3 bound to mCpG is a linear com-
bination of 1DNH for MBD3 bound to CpG(3) (nonspecific














In Equation 3, m is the fraction in the mCpG specific binding
mode and 1DNH(n) are the residual dipolar couplings for each
residue in the MBD3-mCpG, MBD3-CpG, and MBD3KY-
mCpG complexes. Fitting the observed 1DNH to Equation 3 as a
function of m provides the fraction of MBD3 in the methyl-
ation-specific binding mode. As shown in Fig. 5C, the sum of
FIGURE 4. Chemical shifts do not depend on concentration or the pres-
ence of hydroxymethylation. Overlays of 15N HSQC spectra are shown com-
paring MBD3-hmCpG (orange) (A) with MBD3-CpG(3) and MBD3-mCpG at
600 M (blue) and 300 M (red) (B). Resonances for key reporter residues Ala30
and Gly27 are labeled.
FIGURE 5. MBD3 localizes to methylated DNA sites without significant
conformational change. A and B, comparisons of measured 1DNH RDCs nor-
malized to 2H2O quadrupole splitting of 10 Hz are plotted for MBD3-mCpG
versus MBD3-CpG(3) (A) and MBD3-mCpG versus MBD3KY-mCpG complexes
(B). Red dotted ovals highlight those values that fall of the line of identity (gray
line). C, the sum of squared residuals (SSR) is plotted as a function of m (Equa-
tion 3). The sum of squared residuals is minimized (red circle and arrow) at 37%
mCpG bound (m  0.37). D, plotting
1DNH RDCs for MBD3-mCpG observed
versus predicted with m  0.37 (Equation 3) shows good agreement with
tight clustering around y  x. E, the measured 1DNH RDCs for each complex
(MBD3-CpG(3), MBD3KY-mCpG, and MBD3-mCpG, left to right plots, respec-
tively) were fit to the solution structure of MBD3 by singular value decompo-
sition, and the observed versus predicted values were plotted. The Q factors
and correlation coefficients show good agreement with the solution struc-
ture indicating that the backbone structure of MBD3 does not change
between complexes.
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squared residuals between predicted and observed 1DNH is
minimized when m is 0.37. Plotting observed 1DNH,MBD3-mCpG
versus predicted at m  0.37 shows good agreement with tight
clustering around y  x (Fig. 5D). Therefore, using RDCs as an
independent measure of methylation selectivity, we find that
MBD3 spends 37% of the time on the methylated binding site,
which agrees within experimental error with the results from
chemical shift analysis.
The residual dipolar couplings for each complex were fit to
the solution structure of MBD3 bound to hmCpG using singu-
lar value decomposition as implemented by PALES software
(30). Despite the differences in RDCs between complexes, each
data set fit quite well to the MBD3 structure with Q factors of
19.9, 23.1, and 25.9% for the MBD3-mCpG, MBD3-CpG(3),
and MBD3KY-mCpG complexes, respectively (Fig. 5E). There-
fore, the change between methylated and nonspecific binding
modes does not involve backbone structural changes. The
observed chemical shift changes likely reflect a stabilization of
the dynamic loop between 2 and 3 but without significant
structural rearrangements.
MBD2 and MBD3 Distribution Is Influenced by DNA Meth-
ylation Status and CpG Density—In contrast to MBD3, MBD2
appears to spend most of its time on the methylated site (Fig.
6A). The chemical shifts for reporter residues in MBD2 repre-
sent the extrema for the complexes studied. As shown in Fig.
6B, these peaks do not change with increasing DNA length,
indicating that a large 	E dominates the fraction bound to the
methylated site and m  1 (Fig. 3C). The higher affinity and
methylation selectivity of MBD2 results in exclusive occupancy
of mCpG.
Comparing spectra of MBD2 and MBD3 when bound to the
unmethylated oligonucleotides CpG(0), CpG(1), and
CpG(3) reveals that the reporter resonances shift toward the
methylation-specific state with increasing numbers of CpGs
(Fig. 3B; see also Fig. 7A). This finding indicates that both
MBD2 and MBD3 localize to sites of increased CpG density.
MBD3 shows relatively small chemical shift changes when
bound to CpG(3) as compared with CpG(0), consistent
with localizing to a CpG dinucleotide 9% (3%) of the time.
MBD2 shows a pronounced difference between CpG(0) and
CpG(3) (Fig. 6A), showing that MBD2 preferentially localizes
to CpG dinucleotides 33% (11%) of the time. The reporter
resonances also indicate that MBD2, but not MBD3, tends to
localize to hmCpG and exhibits higher affinity for these sites
(Fig. 6A and Table 3). To test whether MBD3 could influence
how MBD2 distributes on unmethylated CpGs, we added
equimolar MBD3 to 15N-MBD2 bound to CpG(3) and found
that the reporter peaks shifted toward those of the nonspecific
binding mode (Fig. 6A). This finding shows that despite rela-
tively weak overall binding affinity, MBD3 can modulate the
distribution of MBD2 on CpG sites, shifting MBD2 toward the
nonspecific binding mode.
Global Binding Affinity Does Not Reflect Localization Prefer-
ences on DNA—Binding affinities for each of the methylated
and unmethylated sequences investigated were determined by
steady state analysis of surface plasmon resonance data, as
described previously (18). To allow for direct comparison of
binding stoichiometry, we normalized the relative steady state
response to the amount of DNA coupled to the sensor chip such
that the maximum steady state response reflects the number of
binding sites on the DNA (25). As can be seen in Fig. 7 and Table
3, both cMBD2 and MBD3KY bind mCpG DNA with high affin-
ity and stoichiometry of approximately one (KD  105  7 nM
and 113  11 nM and Rmax  0.83  0.01 and 0.98  0.02,
respectively). Both bind unmethylated DNA with much lower
affinity and high stoichiometry (KD  74  4 M and 17  2 M
and Rmax  4.8  0.1 and 2.1  0.1, respectively) indicative of a
high degree of methylation selectivity. Although NMR analyses
indicate MBD3 binds DNA with sufficient affinity to be fully
bound at 300 M concentration (Fig. 4B), solubility limits of the
isolated protein preclude accurate determination of binding
constants by surface plasmon resonance. The qualitative results
of these studies, however, are very similar to those reported
previously by Hashimoto et al. (15), who determined DNA
binding affinity for full-length MBD3 by fluorescence anisot-
ropy. In those previous studies, MBD3 bound with similar low
affinity to unmethylated and hydroxymethylated DNA and
with a small but weak preference (5-fold) for methylated
DNA. The current SPR data indicate a small preference for
mCpG as well (Fig. 7).
Likewise, cMBD2 shows similar low affinity and high stoichi-
ometry when binding to hydroxymethylated and unmethylated
DNA with 0 –3 CpG dinucleotides (Fig. 7 and Table 3). There-
fore, global binding analysis reveals a marked preference for
mCpG by cMBD2 and MBD3KY but only weak and nonspe-
cific binding for all other complexes. These findings agree
with several previous DNA binding analyses of MBD pro-
teins (4, 5, 15, 18).
DISCUSSION
Although it has been established that MBD3 binds DNA with
lower affinity and much less specificity for mCpG dinucleotides
than MBD2, the functional role of MBD3 has not been well
defined. Based on NMR structural, chemical shift, and residual
dipolar coupling analyses, we have demonstrated that MBD3
binding to methylated DNA can be described by an ensemble of
FIGURE 6. MBD2 distribution is influenced by DNA methylation status
and CpG density. A, an overlay of 15N HSQC spectra for key reporter residues
of MBD2 bound to CpG(0), CpG(1), CpG(3)  MBD3, mCpG, and hmCpG
shows that cMBD2 preferentially localizes to DNA with mCpG, hmCpG, and
multiple CpG sites and that localization is modified by the presence of
equimolar MBD3. B, an overlay of 15N HSQC spectra cMBD2 bound to mCpG
DNA of varying lengths confirms that cMBD2 strongly prefers mCpG sites.
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methylation-specific and nonspecific binding modes and that
MBD3 preferentially localizes, albeit weakly, to methylated
sites. In contrast, MBD3 does not distinguish between
hydroxymethylated and unmethylated DNA but does show a
slight preference for DNA with multiple CpG dinucleotides. A
similar chemical shift analysis of cMBD2 showed that cMBD2
localizes almost exclusively to the methylated sites when pres-
ent. Even on unmethylated DNA, cMBD2 preferentially local-
izes to CpG dinucleotides, especially as the number of available
CpGs increases. Surprisingly, cMBD2 more avidly localized to a
hydroxymethylated than an unmethylated site. Taken together,
these findings lead to a model in which both MBD2 and MBD3
preferentially localize to DNA with multiple CpGs, whereas
MBD2 more exclusively localizes to mCpGs.
Our studies lead to several novel observations and hypothe-
ses. First, the differences in DNA binding between MBD3 and
MBD2 reflect a change in the degree of selectivity for mCpG,
not absolute differences in binding specificity. As we hypothe-
sized, both MBD2 and MBD3 show a weak preference for CpG
dinucleotides even the absence of methylation; however, MBD2
shows a much greater selectivity for mCpG than MBD3. These
preferences are not necessarily apparent by global binding anal-
yses but instead are reflected in the partitioning between meth-
ylation-specific and nonspecific binding modes on DNA. The
observed changes in the NMR spectra arise from changes in the
distribution of bound states not from changes in the distribu-
tion between bound and free states. In addition, the preference,
although weak, for multiple CpG sites within the relatively
small 17-base pair oligonucleotide used in these studies corre-
lates with the whole genome analyses that show MBD2 and
MBD3 localize to CGIs. Given that a CGI contains 100 –1000
CpG dinucleotides, even a relatively small preference would
lead to fairly strong localization at such sites. Furthermore,
these findings correlate with the observations that both
MBD2 and MBD3 are found at unmethylated CGIs, whereas
MBD2 binds with much greater affinity and likely excludes MBD3
from methylated CGIs. Finally, these studies clearly indicate
that MBD3 does not exhibit a binding preference for or a struc-
tural recognition of hmCpG DNA. From the standpoint of
MBD3, hydroxymethylation is functionally equivalent to
demethylation.
Genomes containing both MBD2 and MBD3 proteins
emerge at the same time as the vertebrate methylation pattern,
which includes largely unmethylated CGIs. This concurrence
along with the preceding characterization of DNA binding by
MBD3 leads us to speculate that MBD3 plays an important role
in regulating genes with unmethylated CGIs. One possibility
these studies raise is that MBD3 helps counterbalance the tend-
ency of MBD2 to preferentially localize to CpG dinucleotides by
competing with MBD2 at unmethylated CGIs. We found that
MBD3 does modify the distribution of MBD2 on DNA such
that MBD2 spends less time on CpG sites. Thus MBD3 could
help prevent gene silencing by MBD2 at unmethylated gene
promoters and enhancers depending on the relative concentra-
tion of the two proteins and cellular context. Indeed, recent
studies have shown that knockdown of MBD3 can lead to
decreased gene expression (16, 17).
Mammalian cells express multiple MBD proteins as well as
different isoforms of individual MBDs. Different splice variants
as well as distinct genes encode for MBD2 and MBD3 proteins,
some of which lack the DNA binding domain itself. Here we
have studied the solution structure and DNA binding of MBD3
by NMR. Chemical shift analyses indicate that MBD3 recog-
nizes and preferentially localizes to both mCpG and CpG sites
but not to the same extent as MBD2. Single amino acid differ-
ences dictate the degree to which these proteins localize on
mCpG sites. Importantly these binding characteristics do not
necessarily lead to changes in global binding affinities but
rather correlate with localization of MBD2 and MBD3 to CGIs
in whole cells. Hence a number of different NuRD complexes
can be formed that show varying degrees of DNA methylation
selectivity and provide distinct functional roles. For MBD3,
these functional differences appear to reflect subtle distinctions
in the behavior of the MBD when bound to methylated and
unmethylated DNA. Therefore, these data establish a structural
basis for the relative distribution of MBD2 and MBD3 on
genomic DNA and help explain their observed occupancy at
CpG-rich promoters.
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